Air delivery conduit

Information

  • Patent Grant
  • 12128184
  • Patent Number
    12,128,184
  • Date Filed
    Tuesday, September 22, 2020
    4 years ago
  • Date Issued
    Tuesday, October 29, 2024
    24 days ago
Abstract
An air delivery conduit for conveying breathable gas from a positive airway pressure device to a patient interface includes a tubular wall structure constructed from a textile material. A reinforcing structure may be provided to the wall structure that is structured to prevent kinking or collapsing of the wall structure. The wall structure may include a warp having a plurality of lengthwise textile warp threads arranged in a circle and a weft having a textile weft thread that is woven through the warp threads.
Description
FIELD OF THE INVENTION

The present invention relates generally to the field of respiratory therapy. More particularly, the invention relates to positive airway pressure devices (PAP devices), respirators, ventilators, CPAP or VPAP devices and conduits that form a component of such devices, the conduits being used for conveying breathing gas from the device to a patient interface.


BACKGROUND
1.0 Introduction

Respiratory devices typically include a flexible conduit to convey a breathing gas such as air to a patient. Generally, the conduit should be strong enough to prevent crushing or kinking, as such could cause occlusions in the conduit thereby restricting or blocking the delivery of breathing gas.


1.1 General Structure

One known conduit structure includes a hard plastic or metal spiral reinforcement around the inside or outside of a thin-walled flexible plastic tube. This helical or spiral structure supports the tube and prevents occlusions. Preferably, the spiral is wound around the outside of the plastic tube so that the conduit maintains a smooth bore, such as in Smooth-Bor® tubing.


1.2 Heat Transfer

Humidified breathing gas may be delivered to a patient as part of their respiratory therapy. In this case, it is advantageous to minimise head transfer out of the conduit in order to avoid condensation of the humidified gas as it flows through the conduit. The condensation problem is particularly pronounced in cold environments.


Plastics and metals are not efficient thermal insulators. Therefore, in order to prevent condensation, additional structure may be added to the conduit. For example, an insulating sleeve may be used to cover the conduit and provide insulation. Another proposed solution involves using a heated wire to heat the conduit (Thermo-Smart® by Fisher & Paykel Healthcare). Actively heating the tube may result in the air temperature rising as it travels along the tube which in turn will result in the air drying out. Smooth-Bor™ also produces a dual-walled conduit that provides added insulation.


1.3 Weight

Present conduits can also be heavy causing an uncomfortable resistance to patient head movements. Additional items, such as an insulating sleeve, added to the conduit may cause the overall weight to increase. Additional items may also increase the friction of the conduit against surrounding items, such as bed linen.


SUMMARY OF THE INVENTION

A first aspect of the invention is to provide a conduit suitable to deliver air from a positive airway pressure device (PAP device), blower, flow generator or ventilator to a patient interface to provide respiratory therapy. In one form the conduit is at least partly constructed from a textile. In one form a wall of the conduit is at least partly constructed from a textile.


In one form, the wall is made from a non-porous, woven textile.


In one form, the textile is woven and porous but is treated such that it is substantially non-porous.


In one form, the textile is a woven textile, manufactured by a circular weaving manufacturing process. Advantageously, the resultant textile is tubular.


In one form, the conduit includes a reinforcing structure and a wall structure, and at least a portion of either the reinforcing structure or the wall structure includes a textile.


A second aspect of the invention is a method for manufacturing a wall of a conduit for conveying air from a respiratory device to a patient interface, the method comprising weaving a textile wall by a circular weaving technique.


Another aspect of the invention relates to an air delivery conduit for conveying breathable gas from a positive airway pressure device to a patient interface. The air delivery conduit includes a tubular wall structure constructed from a textile material and a reinforcing structure provided to the wall structure. The reinforcing structure is structured to prevent kinking or collapsing of the wall structure.


Another aspect of the invention relates to a method for manufacturing an air delivery conduit for conveying breathable gas from a positive airway pressure device to a patient interface. The method includes providing a warp having a plurality of lengthwise textile warp threads arranged in a circle, providing a weft having a textile weft thread, and weaving the weft thread through the plurality of warp threads in a circular weaving technique to produce a tubular wall structure.


Advantageously, textiles (including woven and non-woven textiles) usually provide better insulating properties than plastics and are often lighter in weight. A non-porous textile advantageously prevents breathing gas escaping from the conduit (and the resultant pressure losses).


Other aspects, features, and advantages of this invention will become apparent from the following detailed description when taken in conjunction with the accompanying drawings, which are a part of this disclosure and which illustrate, by way of example, principles of this invention.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings facilitate an understanding of the various embodiments of this invention. In such drawings:



FIG. 1 is a schematic view of an air delivery conduit to deliver air from a PAP device to a patient interface according to an embodiment of the present invention;



FIG. 2 is a perspective view of a textile conduit according to an embodiment of the present invention;



FIG. 3 is a perspective view of a textile conduit with a reinforcing structure according to an embodiment of the present invention; and



FIG. 4 is a perspective view of a textile conduit being formed by a circular weaving manufacturing process according to an embodiment of the present invention.





DETAILED DESCRIPTION OF ILLUSTRATED EMBODIMENTS
2.1 Structure

As schematically shown in FIG. 1, an air delivery conduit 10 is provided that is suitable to deliver air from a positive airway pressure device (PAP device), blower, flow generator, or ventilator 12 to a patient interface 14 to provide respiratory therapy. In one form the conduit 10 is at least partly constructed from a textile.


For example, FIG. 2 illustrates a conduit 10 according to an embodiment of the present invention. As illustrated, a wall or wall structure 20 of the conduit 10 is at least partly constructed from a textile. The conduit 20 may be provided with suitable end portions, e.g., plastic cuffs, that are structured to connect the conduit 10 to each of the PAP device 12 and the patient interface 14.


In one form, the conduit includes a reinforcing structure and a wall structure, and at least a portion of either the reinforcing structure or the wall structure includes a textile. For example, FIG. 3 illustrates a conduit 210 according to another embodiment of the present invention. As illustrated, the conduit 210 includes a wall or wall structure 220 constructed from a textile and a reinforcing structure 230 provided to the wall 220.


In the illustrated embodiment, the reinforcing structure 230 is a spiral structure attached to the textile wall 220 so that the resulting conduit is strong enough to prevent kinking or collapsing. A plastic reinforcing structure 230 that has a spiral/helical shape or a webbing could be used.


2.1.1 Circular Weaving

In an embodiment, the textile is a woven textile, manufactured by a circular weaving manufacturing process. The resultant textile is tubular. In circularly weaved conduits, the warp is circular and there are continuously circulating shuttles running around the periphery.


For example, FIG. 4 illustrates a textile conduit 310 being formed by a circular weaving manufacturing process according to an embodiment of the present invention. As illustrated, the warp 350 includes a plurality of lengthwise textile threads 352 arranged in a circle and the weft 360 includes a textile thread 362 that is woven through the warp threads 352 to make the textile conduit 310.


The textile itself could be made in a way that provides the strength to prevent kinking or obstruction. For example, the weft 360 could be made from a yarn that is semi-rigid, such as a nylon or metal, and the warp 350 would be made from another material that is flexible. This arrangement would result in a tubular structure that is flexible axially but not radially meaning that the tube would be flexible along its length but would prevent kinks and occlusions.


2.2 Ga-Permeability

In one embodiment, the wall of the textile conduit may be made from a non-porous, woven textile while in another embodiment the wall may be made from a substantially porous, woven textile and is treated such that it is substantially non-porous. A non-porous textile prevents breathing gas escaping from the conduit and the resultant pressure losses which could encroach upon the effectiveness of the respiratory therapy.


Gas or air permeability depends on the yarn size and the tightness of the weave. The surface can be treated with a resin to close the pores, or a thin film such as polyethylene may be applied over the surface. In an embodiment, a membrane such as Winstopper® by W. L. Gore & Associates, Inc. may be used. This membrane is permeable to moisture but not gas. The membrane would be applied to the inside of the conduit. If any condensation is formed in the conduit, it will pass through the membrane to the outside of the tube.


2.4 Heat Transfer

A textile conduit may be better insulated than conventional plastic conduits. To provide further insulation to the tube, additional layers of textiles (such as Thinsulate®) may be used.


In one embodiment, insulating material could be provided between each or some of the spiral or other reinforcements and a fabric or other membrane could cover the reinforcements and insulating material. The insulating material could comprise an appropriate closed cell structure, such as a resilient foam.


2.5 Weight

A textile conduit may be lighter in weight than conventional plastic conduits.


2.6 Method of Manufacture

A method for manufacturing a wall of a conduit for conveying air from a respiratory device to a patient interface is also provided. In an embodiment, the method comprises

    • weaving a textile wall by a circular weaving technique. Such a circular weaving technique is discussed above with reference to FIG. 4.


Some of the advantages of using textiles (including woven and non-woven textiles) for a conduit are that they:

    • 1. Have better insulating properties than plastics;
    • 2. Are often lighter in weight than plastics; and/or
    • 3. Have a more natural feel than plastics.


While the invention has been described in connection with what are presently considered to be the most practical and preferred embodiments, it is to be understood that the invention is not to be limited to the disclosed embodiments, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the invention. Also, the various embodiments described above may be implemented in conjunction with other embodiments, e.g., aspects of one embodiment may be combined with aspects of another embodiment to realize yet other embodiments. Further, each independent feature or component of any given assembly may constitute an additional embodiment. In addition, while the invention has particular application to patients who suffer from OSA, it is to be appreciated that patients who suffer from other illnesses (e.g., congestive heart failure, diabetes, morbid obesity, stroke, barriatric surgery, etc.) can derive benefit from the above teachings. Moreover, the above teachings have applicability with patients and non-patients alike in non-medical applications.

Claims
  • 1. A method for manufacturing an air delivery conduit for conveying pressurized gas from a positive airway pressure device to a patient interface for treatment of sleep disordered breathing, comprising: manipulating a plurality of threads to form a tubular shaped air delivery conduit configured to convey the pressurized gas to the patient interface for treatment of sleep disordered breathing;structuring the air delivery conduit to include a tubular wall structure comprising textile material,wherein at least a portion of the wall structure comprising the textile material is configured to directly convey the pressurized gas and forms an outer surface disposed so as to be exposed directly to ambient air, andwherein the conduit includes a non-metallic reinforcing member disposed on the outer surface of the wall structure and configured to prevent collapse of the wall structure.
  • 2. The method of claim 1, wherein the step of manipulating a plurality of threads includes: providing a warp having a plurality of lengthwise warp threads arranged in a circle;providing a weft having a weft thread; andweaving the weft thread through the plurality of warp threads in a circular weaving technique to produce the tubular wall structure.
  • 3. The method of claim 2, wherein the warp is constructed from flexible threads.
  • 4. The method of claim 1, wherein the reinforcing member comprises nylon.
  • 5. The method of claim 1, wherein the reinforcing member is constructed of plastic.
  • 6. The method of claim 1, wherein at least a portion of the reinforcing member is made of a semi-rigid material.
  • 7. The method of claim 1, wherein the textile material is a non-porous, woven textile material.
  • 8. The method of claim 1, wherein the textile material is a porous, woven textile material.
  • 9. The method of claim 8, wherein the porous textile material is treated thereby causing the textile material to become substantially nonporous.
  • 10. The method of claim 1, wherein the step of manipulating a plurality of threads includes manipulating the plurality of threads according to a circular textile- manufacturing technique configured to form the tubular shaped air delivery conduit without seams.
  • 11. The method of claim 1, wherein the textile material comprises resin.
  • 12. The method of claim 1, wherein a surface of the textile material has a thin film thereon.
  • 13. The method of claim 1, wherein the wall structure is arranged to be impermeable to gas.
  • 14. The method of claim 13, wherein the reinforcing member includes a spiral or helical shape.
  • 15. The method of claim 13, wherein the reinforcing member includes a spiral or helical shape and is attached to the wall structure.
  • 16. The method of claim 1, wherein the wall structure comprises a gas impermeable inner layer.
  • 17. The method of claim 1, wherein a surface of the textile material has a gas impermeable material provided thereon.
  • 18. The method of claim 17, wherein the surface of the textile material is an inner surface.
  • 19. The method of claim 1, wherein the tubular wall structure is a seamless tubular wall structure comprising the textile material.
  • 20. The method of claim 19, wherein an inner surface of the textile material has a gas impermeable material provided thereon, and wherein the reinforcing member includes a spiral or helical shape.
Priority Claims (1)
Number Date Country Kind
2006901506 Mar 2006 AU national
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation application of U.S. application Ser. No. 15/425,891 filed Feb. 6, 2017, now U.S. Pat. No. 10,792,452 which is a divisional application of U.S. application Ser. No. 12/225,417, filed Jan. 29, 2009, now U.S. Pat. No. 9,566,408, which was the U.S. National Phase of International Application No. PCT/AU2007/000358, filed Mar. 22, 2007, which designated the U.S. and claimed the benefit of Australian Provisional Application No. AU 2006901506, filed Mar. 24, 2006, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (63)
Number Name Date Kind
2396059 Roberts Mar 1946 A
2813573 Roberts Nov 1957 A
2897840 Roberts Aug 1959 A
3037798 Cooper Jun 1962 A
3163707 Darling Dec 1964 A
3205913 Sperry Sep 1965 A
3312250 Sirignano Apr 1967 A
3709262 Braunschweller Jan 1973 A
3812885 Sajben May 1974 A
3857415 Morin Dec 1974 A
4259991 Kutnyak Apr 1981 A
4276908 Home Jul 1981 A
4308895 Greco Jan 1982 A
4357962 Shaw Nov 1982 A
4415389 Medford Nov 1983 A
4437462 Piljay et al. Mar 1984 A
4478661 Lewis Oct 1984 A
4553568 Piccoli Jan 1985 A
4714096 Guay Dec 1987 A
4842023 Whitworth Jun 1989 A
4848366 Aita et al. Jul 1989 A
5418051 Caldwell May 1995 A
5548842 Wiseman Aug 1996 A
5735266 Smith Apr 1998 A
5800402 Bierman Sep 1998 A
5843542 Brushafer et al. Dec 1998 A
6199676 Targiroff Mar 2001 B1
6508276 Radinger Jan 2003 B2
6769431 Smith et al. Aug 2004 B2
6779522 Smith Aug 2004 B2
7469719 Gray Dec 2008 B2
7481221 Kullik et al. Jan 2009 B2
7926517 Horimoto Apr 2011 B2
8435216 Spinoza May 2013 B2
9566408 Henry Feb 2017 B2
9656038 Rummery May 2017 B2
10729869 Rummery Aug 2020 B2
20010039972 Badders Nov 2001 A1
20010054422 Smith Dec 2001 A1
20020005197 Devries et al. Jan 2002 A1
20030070680 Smith et al. Apr 2003 A1
20040045549 Smith Mar 2004 A1
20040079371 Gray Apr 2004 A1
20040194781 Fukunaga Oct 2004 A1
20040211422 Arcilla et al. Oct 2004 A1
20040226813 Wang Nov 2004 A1
20060165829 Smith Jul 2006 A1
20070207186 Scanlon Sep 2007 A1
20080173305 Frater Jul 2008 A1
20080178957 Thomas Jul 2008 A1
20080202512 Kressierer et al. Aug 2008 A1
20080202620 Van Hooren Aug 2008 A1
20080228028 Carlson et al. Sep 2008 A1
20100018534 Veliss et al. Jan 2010 A1
20100224195 Henry Sep 2010 A1
20100255270 Steubiger Oct 2010 A1
20110303318 Nicolas Dec 2011 A1
20130180615 Ragner Jul 2013 A1
20140102456 Ovizinsky Apr 2014 A1
20160296720 Henry Oct 2016 A1
20170143929 Henry May 2017 A1
20180043120 Hunley Feb 2018 A1
20190015192 Nakazawa Jan 2019 A1
Foreign Referenced Citations (17)
Number Date Country
8014121 Apr 1990 BR
1106101 Aug 1981 CA
393686 Oct 1990 EP
430117 Jun 1991 EP
656352 Aug 1951 GB
05-254164 Sep 1994 JP
9047159 Feb 1997 JP
2001-336678 Dec 2001 JP
2003-275228 Sep 2003 JP
2009-072596 Apr 2009 JP
2014-514035 Jun 2014 JP
2014-167343 Sep 2014 JP
2018-527156 Sep 2018 JP
1682708 Oct 1991 SU
WO 2005075186 Aug 2005 WO
WO 2006047818 May 2006 WO
2012122601 Sep 2012 WO
Non-Patent Literature Citations (22)
Entry
Further Examination Report mailed Jan. 22, 2021 in related NZ Application 756591 (2 pages).
First Examination Report mailed Feb. 12, 2021 in related NZ Application 772270 (3 pages).
Pre-Appeal Examination Report and English translation thereof obtained Nov. 8, 2021 in related JP application 2019-100282 (6 pages).
Office Action mailed Feb. 3, 2022 in related U.S. Appl. No. 16/912,857 (21 pages).
Extended European Search Report mailed Feb. 2, 2023, in related EP Application No. 20756702.5 (8 pages).
Notice of Allowance issued in related Japanese Application No. 2021-547237, three pages, dated Nov. 27, 2023.
Japanese Office Action and English translation mailed Apr. 27, 2020 in JP Application 2019-007016.
Final Office Action mailed Nov. 15, 2019 in related U.S. Appl. No. 15/599,889.
JP Report on the Reexamination Prior to Trial and English translation thereof drafted Aug. 5, 2019 and retrieved from the JPO database Aug. 19, 2019 in related JP application 2017-159153.
Definition of polymer. from Wikipedia, from May 13, 2019, see www.en.wikipedia.org /wiki /Polymer (17 pages).
Non-Final Office Action mailed May 16, 2019 related U.S. Appl. No. 15/599,889 (34 pages).
Further Examination Report mailed Apr. 29, 2019 in related NZ Patent Application No. 740448 (2 pages).
Second Office Action issued in related Chinese Application No. 2016-109065994 dated Jan. 2, 2019, with English translation, (15 pages).
Final Office Action issued in related Japanese Application No. 2017-159153 dated Feb. 15, 2019, with English translation, (8 pages).
A First Office Action issued in related Japanese Application No. 2017-159153 dated Jul. 23, 2018, with English translation, (11 pages).
A First Office Action issued Apr. 4, 2018, in a related Chinese Patent Application No. 201610906599.4 (10 pages), and an English translation thereof (8 pages).
A First Examination Report issued Apr. 3, 2018, in a related New Zealand Patent Application No. 740448 (3 pages).
Notice of Reasons for Rejection and English translation thereof mailed Mar. 22, 2022 in related JP application 2019-100282 (10 pages).
European Search Report mailed Jul. 11, 2022 in related EP Application 21214525.4 (8 pages).
Notice of Reasons for Rejection and English translation thereof mailed Aug. 1, 2022 in related JP Application 2021-146154 (10 pages).
Final Rejection and English translation thereof mailed May 10, 2021 in related JP application 2019-100282 (7 pages).
Notice of Reasons for Refusal and English translation in related Japanese Application No. 2023-220787, four pages, dated Apr. 30, 2024.
Related Publications (1)
Number Date Country
20210001074 A1 Jan 2021 US
Divisions (1)
Number Date Country
Parent 12225417 US
Child 15425891 US
Continuations (1)
Number Date Country
Parent 15425891 Feb 2017 US
Child 17027809 US